TLR9 and neoplasm: Secretion of IFNγ and IL-12 and other inflammatory cytokines via TLR7/8 stimulation enabled NK cells to kill HNSCC and melanoma B16 tumor cells while TLR9 triggered cytotoxic activity of these cells on melanoma cells [44–46].